GLISAXAPIN M 2.5/500
Saxagliptin (2.5mg), Metformin HCI (ER) (500mg)
GLISAXAPIN M 2.5/500 is used to treat type 2 diabetes by combining Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg). Saxagliptin enhances the action of incretin hormones to increase insulin release and reduce glucagon, while Metformin decreases glucose production in the liver and improves insulin sensitivity. Benefits
Comprehensive Blood Sugar Management:
The combination of Saxagliptin and Metformin targets multiple mechanisms to control blood sugar levels.
Extended-Release Formulation: Provides a sustained effect, making it easier for patients to adhere to the treatment regimen.
Weight Management: Metformin helps in controlling weight, a common issue for type 2 diabetes patients.
Cardiovascular Health: Potential benefits for heart health make this combination therapy particularly advantageous.
Lower Hypoglycemia Risk: Compared to other diabetes medications, GLISAXAPIN M 2.5/500 has a lower risk of causing low blood sugar.
Side Effects
Common side effects include:
Digestive Issues: Patients may experience nausea, vomiting, and diarrhea.
Respiratory Tract Infections: Saxagliptin can increase the risk of respiratory infections.
Hypoglycemia: Though rare, low blood sugar can occur, especially if combined with other antidiabetic medications.
Allergic Reactions: Possible skin reactions or swelling.
Lactic Acidosis: A serious but rare side effect of Metformin, characterized by symptoms like muscle pain and breathing difficulties.
Price
The price for GLISAXAPIN M 2.5/500 typically ranges from $50 to $80 for a month’s supply. Many insurance plans cover this medication, reducing the overall cost. Patients should verify their coverage with their insurance providers to understand their out-of-pocket expenses.
Conclusion
GLISAXAPIN M 2.5/500 is a potent combination therapy for managing type 2 diabetes, offering the synergistic benefits of Saxagliptin and Metformin. Its extended-release formulation, effective blood sugar control, and potential cardiovascular benefits make it a valuable option for many patients. Consulting with healthcare providers can help determine if GLISAXAPIN M 2.5/500 is the right choice for individual diabetes management needs.Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma\'s mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 7877551268, 7849827488
Keywords
BUY NOW
lower risk
Dental Care
broad range
Navi Mumbai
muscle pain
right choice
overall cost
GLISAXAPIN M
heart health
common issue
Metformin HCI
many patients
diverse needs
WHO guidelines
online pharmacy
valuable option
pocket expenses
Lactic Acidosis
insulin release
rare conditions
low blood sugar
General Medicine
Nasal Conditions
Digestive Issues
sustained effect
rare side effect
medical community
affordable prices
treatment regimen
incretin hormones
extensive demands
Weight Management
high-quality drugs
glucose production
Respiratory Issues
Allergic Reactions
Potential benefits
blood sugar levels
advanced treatments
multiple mechanisms
insulin sensitivity
healthcare industry
healthcare products
insurance providers
Common side effects
expert professionals
synergistic benefits
healthcare providers
Many insurance plans
Cardiovascular Health
home delivery options
breathing difficulties
respiratory infections
pharmaceutical industry
Lower Hypoglycemia Risk
Possible skin reactions
type 2 diabetes patients
extensive product lineup
Steris Healthcare Pvt Ltd
potent combination therapy
other diabetes medications
Extended-Release Formulation
Respiratory Tract Infections
essential health necessities
effective blood sugar control
other antidiabetic medications
potential cardiovascular benefits
individual diabetes management needs
Comprehensive Blood Sugar Management
